ClinicalTrials.Veeva

Menu

Immune Benefits of WGP in Elderly

N

Nestlé

Status

Completed

Conditions

Elderly People

Treatments

Dietary Supplement: Food fibers
Biological: Influenza vaccine (incl. criterion)
Dietary Supplement: Maltodextrin

Study type

Interventional

Funder types

Industry

Identifiers

NCT02262091
12.22.NRC

Details and patient eligibility

About

The aim of this research is to assess the immune enhancing property of food fibers in the elderly population.

Enrollment

150 estimated patients

Sex

All

Ages

70+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Male and female elderly volunteers equal or above age of 70
  • Pre-frail and frail subjects (based on Fried's criteria)
  • Willing to be vaccinated against influenza and having no contraindication to receive influenza vaccination
  • Having obtained his/her (or his/her legal representative's) informed consent

Exclusion criteria

  • Subject with a rapidly deteriorating health status (terminal, severe, or uncontrolled acute/chronic diseases)
  • Allergy to eggs or influenza vaccine components.
  • Subject who has received any vaccination in the last 3 months or has previously been vaccinated with the current seasonal influenza vaccine.
  • Subject who is currently taking, or has taken in the last 4 weeks, or will take immune modulating medication during the study, including steroid, immune suppressive treatment.
  • Subject who has taken antibiotics in the last 2 months prior to entering the study.
  • Subject who is consuming regularly prebiotic and/or probiotic supplements, yogurts, and/or other dietary supplements.
  • Personal or family history of Guillain-Barre syndrome
  • BMI>35 kg/m2
  • Subject who has received blood transfusion or had a blood donation during the last 4 weeks prior to the beginning of this study.
  • Subject who cannot be expected to comply with the study procedures
  • Currently participating or having participated in another clinical trial during the last 4 weeks prior to the beginning of this study

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

150 participants in 2 patient groups, including a placebo group

Placebo group
Placebo Comparator group
Treatment:
Dietary Supplement: Maltodextrin
Biological: Influenza vaccine (incl. criterion)
Food fibers
Experimental group
Treatment:
Biological: Influenza vaccine (incl. criterion)
Dietary Supplement: Food fibers

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems